<p><strong>Elderly population</strong>: Based on available data, no adjustment of the dosage in geriatric patients is necessary, but greater sensitivity in some older individuals cannot be ruled out.<br />
<strong>Renal impairment</strong>: It has not been studied in subjects with renal impairment.<br />
<strong>Hepatic impairment</strong>: It has not been studied in subjects with hepatic impairment.<br />
<strong>Pediatric population</strong>: It is not indicated for use in children and adolescents. The safety and efficacy in pediatric patients (aged 17 years and younger) have not been established.</p>